Why is Core Scientific stock down today?

Traders Union
All News
Financial News
Core scientific slides 4.98% today

Highlights

Core Scientific trades below short- and medium-term moving averages but remains above its long-term support, signaling longer-term bullish alignment amid near-term selling pressure.
Momentum and breadth indicators show growing oversold conditions and weak trend strength, with short-term sentiment weighed by increased seller activity after a pronounced opening gap down.
Forecasted five-session price range is $19.74–$23.61, with a slight downside bias and consolidation likely near current levels unless a breakout or breakdown occurs.

Anton Kharitonov, expert at Traders Union, warns that Core Scientific's technical structure is deteriorating. He notes persistent selling pressure and clear breaks below 20-day and 50-day moving averages. Critical momentum indicators confirm a bearish environment, with RSI, CCI, and BBP signaling oversold conditions. The lack of news or catalysts increases market vulnerability, making random selling likely. "I see further downside risk because sentiment is fragile and technicals give no sign of a reliable rebound yet," Kharitonov says.

Viktoras Karapetjanc, expert at Traders Union, points out the absence of fundamental headwinds despite the corrective price move. He highlights that the stock stays above the 200-day average, indicating intact long-term bullish structure. Karapetjanc sees oversold momentum as an opportunity for positional buyers if stability emerges. He believes that market participants should monitor for upward confirmation above $23.61. "Further growth remains likely as the bullish foundation is unbroken and new setups could arise on any positive shift," Karapetjanc asserts.

Jainam Mehta, market strategist, observes a technical-macro tug-of-war in Core Scientific. He sees the stock trapped between short-term weakness and long-term support. The recent volatility and mixed momentum signal a tactical wait-and-see approach. "A decisive move beyond the $19.74 to $23.61 range could present a fresh directional setup for active traders," Mehta notes.

Short-term pressure and oversold signals as longer trend holds

Core Scientific sits below both its 20-day and 50-day moving averages at $26.72 and $25.03, but remains above the 200-day moving average at $19.27. This setup signals continued longer-term bullish alignment, though the stock is under short- and medium-term technical pressure; the closest resistance is near-term ceiling at $22.2, with support at the near-term floor of $21.07. Momentum indicators present a mixed and volatile short-term picture. The Moving Average Convergence Divergence (MACD) is neutral, while the Average Directional Index (ADX) signals declining trend strength and likely seller dominance. The Relative Strength Index (RSI) sits at 37.17 with a "Sell" outlook, indicating emerging oversold conditions, which is confirmed by the Commodity Channel Index (CCI) at -183.54 and Bull/Bear Power (BBP) at -2.45, both in oversold territory. Stochastic RSI shows a strong buy from deeply oversold levels, contrasting the negative Awesome Oscillator (AO) and recent price action. The stock is currently trading at $21.67, down 4.98% on the day after opening with a downside gap of roughly $0.77 (about 3.38%), with price now mid-range and intraday volatility at 7.09%. Sentiment is weighed down by seller pressure after the open, but oversold readings are building.

Earlier, analysts noted that Core Scientific was under persistent bearish momentum and faced elevated downside risks amid technical headwinds. The current setup reinforces this view, as short- and medium-term technical weakness persists and traders should closely watch for a decisive break below $19.74, which could accelerate further declines.

Source of Data: CORZ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.